These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease. Kim Y, Park HC, Ryu H, Kim YC, Ahn C, Lee KB, Kim YH, Han S, Bae EH, Jeong K, Choi J, Oh KH, Oh YK. J Korean Med Sci; 2023 Sep 25; 38(38):e296. PubMed ID: 37750370 [Abstract] [Full Text] [Related]
13. Clinical experience with white blood cell-PET/CT in autosomal dominant polycystic kidney disease patients with suspected cyst infection: A prospective case series. Kim H, Oh YK, Park HC, Park S, Lee S, Lee HY, Hwang YH, Ahn C. Nephrology (Carlton); 2018 Jul 25; 23(7):661-668. PubMed ID: 28565035 [Abstract] [Full Text] [Related]
14. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, Rossetti S, Harris PC, LaRusso NF, Torres VE. J Am Soc Nephrol; 2010 Jun 25; 21(6):1052-61. PubMed ID: 20431041 [Abstract] [Full Text] [Related]
16. A Rare Case of Pelvic Organ Prolapse in a Nulliparous Female With Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Polycystic Liver Disease (PLD). Hechter S, Ganta N, Kochhar S, Kanukuntla A, Kata P, Turro J, Cheriyath P. Cureus; 2021 Nov 25; 13(11):e20023. PubMed ID: 34987911 [Abstract] [Full Text] [Related]
20. Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease. Kim H, Park HC, Ryu H, Kim K, Kim HS, Oh KH, Yu SJ, Chung JW, Cho JY, Kim SH, Cheong HI, Lee K, Park JH, Pei Y, Hwang YH, Ahn C. PLoS One; 2015 Nov 25; 10(12):e0144526. PubMed ID: 26641645 [Abstract] [Full Text] [Related] Page: [Next] [New Search]